TW
The Washington Post
@washingtonpost.com
Democracy Skies in Blueness
294.1k followers58 following4.2k posts
Breaking news: In a major advance, the FDA on Friday approved two gene therapies that target sickle cell disease, one of which is the first commercially available treatment in the United States based on gene editing technology
FDA approves two sickle cell therapies, including the first CRISPR medicine
The therapies offer hope for a long-overlooked genetic illness that can cause excruciating pain and cut decades off people’s lives.
Wow, we could use more positive news like this.
Great news!
Excellent news
TW
The Washington Post
@washingtonpost.com
Democracy Skies in Blueness
294.1k followers58 following4.2k posts